ArticlePloS one2015

Molecular interaction of a kinase inhibitor midostaurin with anticancer drug targets, S100A8 and EGFR: transcriptional profiling and molecular docking study for kidney cancer therapeutics.

Zeenat Mirza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.